Cargando…
Application of CRISPR/Cas9 in Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive and irreversible neurodegenerative disorder clinically characterized by cognitive impairment, abnormal behavior, and social deficits, which is intimately linked with excessive β-amyloid (Aβ) protein deposition along with many other misfolded proteins, neurof...
Autores principales: | Lu, Likui, Yu, Xi, Cai, Yongle, Sun, Miao, Yang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724030/ https://www.ncbi.nlm.nih.gov/pubmed/34992519 http://dx.doi.org/10.3389/fnins.2021.803894 |
Ejemplares similares
-
CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis
por: Shi, Yajun, et al.
Publicado: (2023) -
Development of CRISPR Cas9, spin-off technologies and their application in model construction and potential therapeutic methods of Parkinson’s disease
por: Qu, Jiangbo, et al.
Publicado: (2023) -
CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
por: Yang, Weili, et al.
Publicado: (2016) -
Applications of CRISPR-Cas9 in Alzheimer’s Disease and Related Disorders
por: De Plano, Laura M., et al.
Publicado: (2022) -
Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
por: Giau, Vo Van, et al.
Publicado: (2018)